Augmentation Vs. Switch Approaches for Treatment-Resistant Depression in Older Adults: Methods and Main Results From the Optimum Study and Considerations for Ketamine in Late-Life.

Jordan F Karp

講演情報

[CINP2024] Symposia

CINP2024 » Symposia

Symposium 21
Late-Life Treatment Resistant Depression: Advances in pharmacotherapy, brain stimulation, and brain-based mechanisms of treatment response variability.

2024年5月26日(日) 10:45 〜 12:00 Room 2 (Hall B7 (1))

Chair: Jordan F Karp (Tucson, University of Arizona)

[IS21-1] Augmentation Vs. Switch Approaches for Treatment-Resistant Depression in Older Adults: Methods and Main Results From the Optimum Study and Considerations for Ketamine in Late-Life.

*Jordan F Karp^1,2 (1. 1Department of Psychiatry, College of Medicine – Tucson, University of Arizona, Tucson, AZ, 2. 2Banner University Medical Center and Group, Tucson, AZ)

キーワード：Depression, Treatment resistant depression, Geriatric, Well-being, Falls

抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。

講演情報

Symposium 21Late-Life Treatment Resistant Depression: Advances in pharmacotherapy, brain stimulation, and brain-based mechanisms of treatment response variability.

[IS21-1] Augmentation Vs. Switch Approaches for Treatment-Resistant Depression in Older Adults: Methods and Main Results From the Optimum Study and Considerations for Ketamine in Late-Life.

パスワード

Symposium 21
Late-Life Treatment Resistant Depression: Advances in pharmacotherapy, brain stimulation, and brain-based mechanisms of treatment response variability.